全文获取类型
收费全文 | 311767篇 |
免费 | 16454篇 |
国内免费 | 687篇 |
专业分类
耳鼻咽喉 | 4076篇 |
儿科学 | 9939篇 |
妇产科学 | 6948篇 |
基础医学 | 44107篇 |
口腔科学 | 8197篇 |
临床医学 | 24230篇 |
内科学 | 70494篇 |
皮肤病学 | 9022篇 |
神经病学 | 27445篇 |
特种医学 | 8913篇 |
外国民族医学 | 129篇 |
外科学 | 39554篇 |
综合类 | 1591篇 |
一般理论 | 86篇 |
预防医学 | 28155篇 |
眼科学 | 5960篇 |
药学 | 21484篇 |
中国医学 | 1006篇 |
肿瘤学 | 17572篇 |
出版年
2023年 | 1687篇 |
2022年 | 2321篇 |
2021年 | 6038篇 |
2020年 | 3450篇 |
2019年 | 6251篇 |
2018年 | 9738篇 |
2017年 | 6468篇 |
2016年 | 6579篇 |
2015年 | 7187篇 |
2014年 | 8511篇 |
2013年 | 12927篇 |
2012年 | 20609篇 |
2011年 | 20896篇 |
2010年 | 10974篇 |
2009年 | 8964篇 |
2008年 | 17487篇 |
2007年 | 18585篇 |
2006年 | 17276篇 |
2005年 | 17357篇 |
2004年 | 16087篇 |
2003年 | 14864篇 |
2002年 | 14075篇 |
2001年 | 8420篇 |
2000年 | 8483篇 |
1999年 | 7457篇 |
1998年 | 1798篇 |
1997年 | 1431篇 |
1996年 | 1316篇 |
1995年 | 1180篇 |
1994年 | 983篇 |
1992年 | 4013篇 |
1991年 | 3667篇 |
1990年 | 3465篇 |
1989年 | 3099篇 |
1988年 | 2911篇 |
1987年 | 2765篇 |
1986年 | 2624篇 |
1985年 | 2406篇 |
1984年 | 1786篇 |
1983年 | 1510篇 |
1979年 | 1520篇 |
1978年 | 1066篇 |
1975年 | 1041篇 |
1974年 | 1240篇 |
1973年 | 1240篇 |
1972年 | 1170篇 |
1971年 | 1156篇 |
1970年 | 1097篇 |
1969年 | 1132篇 |
1968年 | 993篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
43.
44.
45.
Rosario Gulias-Cañizo Anell Lagunes-Guillén Arturo González-Robles Erika Sánchez-Guzmán Federico Castro-Muñozledo 《Burns : journal of the International Society for Burn Injuries》2019,45(2):398-412
Background
Since recent reports have shown that (-)-Epigallocatechin-3-gallate (EGCG) could be used for treating proliferative and inflammatory disorders, we explored its use for the management of corneal chemical burns.Materials and methods
Initially, EGCG was assayed on the rabbit corneal epithelial cell line RCE1(5T5) to establish the best testing conditions, and to avoid unwanted outcomes in the experimental animals. Then, we studied its effects on cell proliferation, cell cycle progression and cell differentiation. Afterwards, we instilled EGCG in experimental grade II corneal alkali burns in mice, three times a day up to 21 days, and evaluated by slit lamp examination and histological sections of corneal epithelial, corneal endothelial and stromal edema, as well as the presence of inflammatory cells and neovascularization.Results
EGCG reduced cell growth and led to a decline in the proportion of proliferative cells in a concentration dependent manner. At 10 μM, EGCG promoted cell differentiation, an effect not related with apoptosis or cytotoxicity. When 10 μM EGCG was instilled in corneal alkali burns in mice three times a day up to 21 days, EGCG significantly reduced corneal opacity and neovascularization. The improved clinical appearance of the cornea was associated to a controlled epithelial growth; epithelial morphology was similar to that observed in normal epithelium and contrasted with the hyperproliferative, desquamating epithelium observed in control burn wounds. EGCG reduced corneal, stromal and endothelial edema, and wound inflammation.Conclusion
This work constitutes the first evidence for the use of EGCG in the acute phase of a corneal alkali burn, representing a possible novel alternative to improve patient outcomes as an add-on therapy. 相似文献46.
47.
48.
49.
Enrique Luengo Izaskun Buendia Cristina Fernndez‐Mendívil Paula Trigo‐Alonso Pilar Negredo Patrycja Michalska Borja Hernndez‐García Cristina Snchez‐Ramos Juan A. Bernal Tsuneya Ikezu Rafael Len Manuela G. Lpez 《Journal of pineal research》2019,67(1)
Alterations in autophagy are increasingly being recognized in the pathogenesis of proteinopathies like Alzheimer's disease (AD). This study was conducted to evaluate whether melatonin treatment could provide beneficial effects in an Alzheimer model related to tauopathy by improving the autophagic flux and, thereby, prevent cognitive decline. The injection of AAV‐hTauP301L viral vectors and treatment/injection with okadaic acid were used to achieve mouse and human ex vivo, and in vivo tau‐related models. Melatonin (10 μmol/L) impeded oxidative stress, tau hyperphosphorylation, and cell death by restoring autophagy flux in the ex vivo models. In the in vivo studies, intracerebroventricular injection of AAV‐hTauP301L increased oxidative stress, neuroinflammation, and tau hyperphosphorylation in the hippocampus 7 days after the injection, without inducing cognitive impairment; however, when animals were maintained for 28 days, cognitive decline was apparent. Interestingly, late melatonin treatment (10 mg/kg), starting once the alterations mentioned above were established (from day 7 to day 28), reduced oxidative stress, neuroinflammation, tau hyperphosphorylation, and caspase‐3 activation; these observations correlated with restoration of the autophagy flux and memory improvement. This study highlights the importance of autophagic dysregulation in tauopathy and how administration of pharmacological doses of melatonin, once tauopathy is initiated, can restore the autophagy flux, reduce proteinopathy, and prevent cognitive decline. We therefore propose exogenous melatonin supplementation or the development of melatonin derivatives to improve autophagy flux for the treatment of proteinopathies like AD. 相似文献
50.